Centers for Medicare and Medicaid Services (CMS) News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Hospital Makes a House Call
In a time of strained capacity, the “hospital at home” movement is figuring out how to create an inpatient level of care anywhere. (Source: NYT Health)
Source: NYT Health - January 26, 2023 Category: Consumer Health News Authors: Helen Ouyang Tags: Health Insurance and Managed Care Hospitals Coronavirus (2019-nCoV) Emergency Medical Treatment Rural Areas CMS Innovation Center (Centers for Medicare and Medicaid Services) Source Type: news
Study Comparing Data from Hospitals and Insurers Finds Major Hospitals Still Not Complying with Price Transparency Law
But insurers are complying under the Transparency in Coverage regulations and that is where discrepancies in the disclosure of prices to the public have been found Despite federal regulations requiring hospitals to publicly post their prices in advance of patient services, some large health systems still do not follow the law. That’s according to a […]
The post <strong>Study Comparing Data from Hospitals and Insurers Finds Major Hospitals Still Not Complying with Price Transparency Law</strong> appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - January 25, 2023 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Coding, Billing, and Collections Compliance, Legal, and Malpractice Laboratory Management and Operations Laboratory News Laboratory Testing anatomic pathology Ascension Health centers for medicare and medicaid services clinical laboratory Source Type: news
Emailing Your Doctor May Carry a Fee
More hospitals and medical practices have begun charging for doctors ’ responses to patient queries, depending on the level of medical advice. (Source: NYT Health)
Source: NYT Health - January 24, 2023 Category: Consumer Health News Authors: Benjamin Ryan Tags: Health Insurance and Managed Care Computers and the Internet Hospitals Prices (Fares, Fees and Rates) Doctors Coronavirus (2019-nCoV) E-Mail Electronic Health Records Medicare Telemedicine Centers for Medicare and Medicaid Services Source Type: news
Regulators Announce Changes to Nursing Home Rating System
The federal agency that oversees nursing homes has tightened rules around the use of powerful antipsychotic drugs. (Source: NYT Health)
Source: NYT Health - January 18, 2023 Category: Consumer Health News Authors: Katie Thomas, Robert Gebeloff and Jessica Silver-Greenberg Tags: Nursing Homes Elderly Elder Care Schizophrenia Regulation and Deregulation of Industry Mental Health and Disorders Centers for Medicare and Medicaid Services your-feed-healthcare Source Type: news
CMS: Agency Information Collection Activities: Proposed Collection; Comment Request
The Centers for Medicare and Medicaid Services is seeking comment on the following information collections: 1) Medicaid Managed Care and Supporting Regulations; 2) Testing Experience and Functional Tools (TEFT): Functional Assessment Standardized Items (FASI) Based on the CARE Tool; 3) the Home Health Care CAHPS ® Survey (HHCAHPS); and 4) Collection of Diagnostic Data in the Abbreviated RAPS Format. Comments are due by March 20, 2023. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - January 17, 2023 Category: Rural Health Source Type: news
CMS Announces Increase in 2023 in Organizations and Beneficiaries Benefiting from Coordinated Care in Accountable Care Relationship
Announcement from the Centers for Medicare and Medicaid Services detailing three accountable care initiatives for 2023, the Medicare Shared Savings Program, the Accountable Care Organizations Realizing Equity, Access, and Community Health (ACO REACH) Model, and the Kidney Care Choices (KCC) Model. These initiatives are expected to drive growth in participation, particularly in rural and underserved areas. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - January 17, 2023 Category: Rural Health Source Type: news
Why It ’s Hard to Get the New Alzheimer’s Drug Lecanemab
Alzheimer’s patients and their families welcomed the news on Jan. 6 that the U.S. Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s disease. Lecanemab, marketed as Leqembi, is made by Eisai and Biogen for people in the early stages of the disease. The FDA granted lecanemab accelerated approval based on early phase testing results, and it’s now reviewing the companies’ completed data for consideration of traditional, full approval. It’s only the second drug approved to treat Alzheimer’s, not just address symptoms.
Doctors can now prescribe the medication, but man...
Source: TIME: Health - January 9, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Aging healthscienceclimate Source Type: news
CMS Awards 200 New Medicare-Funded Residency Slots to Hospitals Serving Underserved Communities
Announces that the Centers for Medicare and Medicaid Services (CMS) has awarded the first 200 of 1,000 Medicare-funded physician residency slots to 100 teaching hospitals across 30 states, the District of Columbia, and Puerto Rico. One hundred twenty-five of the residency slots are allocated for primary care, including obstetrics/gynecology, and 20 slots are allocated for psychiatry. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - January 9, 2023 Category: Rural Health Source Type: news
FDA Approves, Leqembi, New Treatment for Early Alzheimer ’s
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments. (Source: NYT Health)
Source: NYT Health - January 6, 2023 Category: Consumer Health News Authors: Pam Belluck Tags: Drugs (Pharmaceuticals) Alzheimer ' s Disease Clinical Trials Medicare Placebos Labeling and Labels (Product) Aduhelm (Drug) Biogen Inc Centers for Medicare and Medicaid Services Eisai Co Ltd Food and Drug Administration New Engl Source Type: news
FDA Approves Lecanemab, a New Alzheimer ’s Drug
On Jan. 6, the U.S. Food and Drug Administration (FDA) approved a new drug to treat Alzheimer’s disease in its early stages.
Lecanemab, which will be available under the name Leqembi, can slow the cognitive decline associated with Alzheimer’s disease by 27%, according to data submitted to the FDA by the drug’s developers, Eisai and Biogen. It’s only the second medication to show any improvement in neurodegeneration, a key criterion in the FDA’s consideration for approval.
“For a long time, this is what we have been looking for,” says Dr. Sam Gandy, professor of neurology and psychi...
Source: TIME: Health - January 6, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news
CMS: Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Organ Acquisition; Rural Emergency Hospitals: Payment Policies, Conditions of Participation, Provider Enrollment, Physician Self-Referral; New Service Category for Hospital Outpatient Department Prior Authorization Process; Overall Hospital Quality Star Rating; COVID-19; Correction
Notice from the Centers for Medicare and Medicaid Services (CMS) making technical corrections to theNovember 23, 2022, final rule. This correction is effective January 1, 2023. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - January 4, 2023 Category: Rural Health Source Type: news
CMS: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model; Correction
Notice from the Centers for Medicare and Medicaid Services (CMS) making technical corrections to theNovember 7, 2022, final rule. This correction is effective January 1, 2023. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - December 30, 2022 Category: Rural Health Source Type: news
CMS: Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications
Notice of proposed rule from the Centers for Medicare and Medicaid Services to amend regulations for Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), Medicare cost plan, and Programs of All-Inclusive Care for
the Elderly (PACE), among other things. Comments on the proposed changes are due by February 13, 2023. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - December 27, 2022 Category: Rural Health Source Type: news
CMS: Agency Information Collection Activities: Proposed Collection; Comment Request
The Centers for Medicare and Medicaid Services is seeking comment on the following information collections: 1) End-stage Renal Disease (ESRD) Quality Incentive Program (QIP): Study of Quality and Patient Experience; and 2) Electronic Funds Transfer (EFT) Authorization Agreement. Comments are due February 21, 2023. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - December 22, 2022 Category: Rural Health Source Type: news
CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request
The Centers for Medicare and Medicaid Services is seeking comment on the following information collections: 1) Medicare Registration Application, which is used to determine whether or not providers meet certain qualifications to enroll in the Medicare program for the sole purpose of ordering or certifying certain Medicare items or services; and 2) Medicare Enrollment Application for Physician and Non-Physician Practitioners, which is used to gather information about providers in order to establish correct Medicare claims payment. Comments are due by January 20, 2023. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - December 21, 2022 Category: Rural Health Source Type: news
